Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

4 big analyst picks: Corning upgraded to Buy on margin recovery potential

Published 2023-06-16, 04:58 a/m
© Reuters.

Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: upgrades at Corning, AutoZone, Kohl's, and MorphoSys.

InvestingPro subscribers got this news before anyone else. Start your 7-day trial to get on board.

Corning upgraded to Buy at Citi

Citi upgraded Corning (NYSE:GLW) to Buy from Neutral and raised its price target to $40.00 from $36.00, as InvestingPro reported in real time.

The upgrade was based on increased confidence in margin expansion targets following recent Display price increases in a tighter supply-demand environment. Additionally, the firm sees improved productivity enhancements in the Optical segment offsetting a moderated demand outlook.

Furthermore, the company's improving FCF generation, driven by better working capital and modest capital expenditures, could lead to a resumption in share repurchases.

InvestingPro | Unlock the Market's

AutoZone earns another upgrade

UBS upgraded AutoZone (NYSE: NYSE:AZO) to Buy from Neutral and raised its price target to $2,900.00 from $2,800.00.

Shares gained more than 4% yesterday after the company announced a repurchase of an additional $2.0 billion of its common stock in connection with its ongoing share repurchase program.

Earlier this week, Evercore ISI upgraded the company to Outperform from In Line with a price target of $2,700.00 (from $2,640.00), noting that the recent decline in share price since reporting lower-than-expected Q3 sales last month gives the stock a more attractive entry point.

2 more upgrades

Kohl’s (NYSE:KSS) shares gained more than 2% yesterday after TD Cowen upgraded the company to Outperform from Market Perform and raised its price target to $30.00 from $23.00. The firm believes the new CEO's practical retail strategies can succeed after years of insufficient change.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

JPMorgan upgraded MorphoSys (NASDAQ:MOR) to Overweight from Underweight and raised its price target to $10.00 from $3.30. Shares jumped more than 13% pre-market today.

Jump on the biggest news for your portfolio amid a barrage of market headlines: Always be the first to know with InvestingPro.

Start your free 7-day trial now.

InvestingPro | Be The First To Know

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.